Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling

  • End date
    Nov 22, 2024
  • participants needed
  • sponsor
    Suthat Liangpunsakul
Updated on 22 April 2022
Accepts healthy volunteers


The main purpose of this study is to see whether heavy drinking will interfere with a specific pathway, called FXR signaling in the liver. The abnormality of this pathway may lead to liver injury in some patients who drink heavily.

Condition Alcohol Consumption
Treatment Placebo, 10 mg Obeticholic Acid (OCA)
Clinical Study IdentifierNCT02654236
SponsorSuthat Liangpunsakul
Last Modified on22 April 2022


Yes No Not Sure

Inclusion Criteria

Individuals ≥ 21 to 65 years old
Able to provide informed consent & negative urine pregnancy test where appropriate
Healthy controls must have not consumed any alcohol within 3 months prior to the screening visit
Heavy alcohol drinking is defined as > 40 grams per day on average in women and > 60 grams per day on average in men for a minimum of 6 months
Women of child bearing potential should be willing to practice contraception throughout the treatment period

Exclusion Criteria

Active infection as evidenced by positive urine culture, blood culture, or pneumonia
Serum creatinine > 1.5 mg/dL
Known co-existing infection with hepatitis C, hepatitis B, or HIV
Significant systemic or major illness including COPD, CHF and renal failure that in the opinion of the Investigator would preclude the patient from participating in and completing the study
Participation in another investigational drug, biologic, or medical device trial within 30 days prior to Screening
Previous history of jaundice or signs of liver diseases such as spider angiomata, ascites, or history of esophageal varices or hepatic encephalopathy
Total bilirubin > 2 mg/dl and INR > 1.5 Page 20 of 37
Women who are pregnant or nursing
Presence of any other disease or condition that is interfering with the absorption, distribution, metabolism, or excretion of drugs including bile salt metabolism in the intestine. Patients who have undergone gastric bypass procedures will be excluded (gastric lap band is acceptable)
Subjects who are taking warfarin
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note